Susquehanna International Group, LLP Cor Medix Inc. Put Options Transaction History

Susquehanna International Group, LLP

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$3.64 - $8.23 $91,728 - $207,396	-25,200 Reduced 10.2%	221,900 $1.79 Million
Q2 2024 Aug 15, 2024	BUY	$4.08 - $6.39 $239,088 - $374,454	58,600 Added 31.09%	247,100 $1.07 Million
Q1 2024 May 07, 2024	SELL	$2.94 - $4.24 $74,088 - $106,848	-25,200 Reduced 11.79%	188,500 $799,000
Q4 2023 Feb 14, 2024	SELL	$3.0 - $4.01 $57,600 - $76,992	-19,200 Reduced 8.24%	213,700 $803,000
Q3 2023 Nov 14, 2023	BUY	$3.6 - $4.46 $236,160 - $292,576	65,600 Added 39.21%	232,900 $861,000
Q2 2023 Aug 11, 2023	BUY	$3.94 - $5.8 $175,330 - $258,100	44,500 Added 36.24%	167,300 $662,000
Q1 2023 May 16, 2023	SELL	$3.22 - $4.61 $185,794 - $265,997	-57,700 Reduced 31.97%	122,800 $508,000
Q4 2022 Feb 14, 2023	BUY	$2.81 - $4.45 $292,802 - $463,690	104,200 Added 136.57%	180,500 $761,000
Q3 2022 Nov 14, 2022	BUY	$2.82 - $7.52 $54,426 - $145,136	19,300 Added 33.86%	76,300 $216,000

104

17.4M

134K

441K

Ticker CRMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,208,200
Market Cap $426M
Description
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.